Publications by authors named "Richard Lomas"

Claim this Profile
D
Decellularized dermis allograft for the treatment of venous leg ulceration: the DAVE RCT.
Sarah Onida, Matthew Tan, Valeria Balan, Francine Heatley, Sarrah Peerbux, Richard Lomas

Br J Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Examination of Potential Deceased Organ and Tissue Donors: An Overview of the European Landscape.
Akila Chandrasekar, Richard Lomas, Jacinto Sánchez-Ibáñez, Mar Lomero, Arlinke Bokhorst

Transpl Int· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
28 Validation of a closed system for dispensing serum eye drops.
Penny Hogg, Roisin Vere, Dwynwen Elen, Richard Lomas, Akila Chandrasekar

BMJ Open Ophthalmol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2 Impact of COVID-19 on a national serum eyedrops programme in the UK.
Lauren Roberts, Richard Lomas

BMJ Open Ophthalmol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol for a multicentre, randomised controlled trial to compare the use of the decellularised dermis allograft in addition to standard care versus standard care alone for the treatment of venous leg ulceration: DAVE trial.
Sarah Onida, Francine Heatley, Sarrah Peerbux, Layla Bolton, Tristan Lane, Richard Lomas

BMJ Open· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EuroGTP II: a tool to assess risk, safety and efficacy of substances of human origin.
Esteve Trias, Richard Lomas, Jaime Tabera, A Rita Piteira, Kelly Tilleman

Int J Qual Health Care· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Interventions for Diabetic Foot Ulcer Treatment Trial (MIDFUT): study protocol for a randomised controlled trial.
Sarah Brown, Jane Nixon, Myka Ransom, Rachael Gilberts, Nikki Dewhirst, Richard Lomas

BMJ Open· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone allograft in the U.K.: perceptions and realities.
Richard Lomas, Akila Chandrasekar, Timothy N Board

Hip Int· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of amniotic membrane preparation method on its ability to serve as a substrate for the ex-vivo expansion of limbal epithelial cells.
Alex J Shortt, Genevieve A Secker, Richard J Lomas, Stacy P Wilshaw, John N Kearney

Biomaterials· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a bacteriophage model system to investigate virus inactivation methods used in the treatment of bone allografts.
Carol Bienek, Lynsay MacKay, Gillian Scott, Anthony Jones, Richard Lomas

Cell Tissue Bank· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiofrequency-generated glow discharge treatment: potential benefits for polyester ligaments.
John Richard James Rowland, Satoshi Tsukazaki, Toshiyuki Kikuchi, Kyosuke Fujikawa, John Kearney, Richard Lomas

J Orthop Sci· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis